EXPD Shorts Hold Steady After Earnings; Street Trims Doubts

Expeditors International of Washington reported Q3 results on November 3 and the short position that had built ahead of the print has barely budged, while the Street moved to close the gap between its targets and a stock trading at $204.31.

Short interest came into the week at 3.5% of the free float, essentially unchanged from where it sat before the earnings release. The 0.5% weekly rise is negligible. What has shifted is the cost to borrow, which jumped 25% over the week to 0.50%, reversing the sharp drop seen in the days before the print. Even so, the borrow market remains far from stressed. Availability is essentially unlimited at the current short position size, with roughly 127 million shares available against fewer than 5 million shorted. The post-earnings short book looks like a residual position rather than fresh conviction: costs are rising but from a very low base, and there is no pressure on existing shorts to cover.

The more interesting story this week is on the analyst side. Truist Securities raised its target from $175 to $200, keeping a Hold rating, the latest in a series of upward revisions since late September. JP Morgan lifted to $214 (Neutral) and UBS moved to $220 (Buy) in early October. The consensus mean target is $189.47, which now sits below the current price of $204.31, a gap that reflects how quickly the stock has moved past where analysts were willing to follow. Barclays remains the outlier with an Underweight and a $165 target. The factor picture adds some texture: the EPS surprise score ranks in the 79th percentile, and earnings momentum over 90 days is in the 72nd, both consistent with a company that has been delivering above expectations. Value metrics are less flattering, with EV/EBITDA at 17.7 and a P/E of 23.9, and the earnings yield factor at the 33rd percentile suggests the stock is not cheap by its own history.

One data point worth noting: Wikipedia page views for EXPD are running more than two standard deviations above the company's own 90-day average as of late October, a sign of elevated retail attention after the earnings release. This is an attention signal, not a revenue indicator, but it does align with the post-results price move and the week's general uptick in coverage.

The October 31 note flagged a short-side buildup ahead of earnings with no squeeze pressure. That picture holds. The shorts did not cover en masse after the November 3 print, the stock rose 1.9% on the day, and the residual position now carries a slightly higher borrow cost. Closest peer CHRW fell 7% over the week while UPS added 2.9% and FDX gained 3.6%, leaving Expeditors broadly in line with the larger names but clearly ahead of the broker segment. The next scheduled earnings date is February 16, 2027, with 104 days to go. The question between now and then is whether the consensus target distribution, still anchored well below the current price, begins to shift upward or whether the stock drifts back toward where analysts are comfortable.